The stock of Novadaq Technologies Inc. (NASDAQ:NVDQ) hit a new 52-week low and has $6.97 target or 7.00% below today’s $7.49 share price. The 8 months bearish chart indicates high risk for the $432.52M company. The 1-year low was reported on Nov, 29 by Barchart.com. If the $6.97 price target is reached, the company will be worth $30.28 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 647,182 shares traded hands or 82.79% up from the average. Novadaq Technologies Inc. (NASDAQ:NVDQ) has declined 39.62% since April 26, 2016 and is downtrending. It has underperformed by 44.87% the S&P500.
Analysts await Novadaq Technologies Inc. (NASDAQ:NVDQ) to report earnings on February, 15. They expect $-0.15 EPS, up 11.76% or $0.02 from last year’s $-0.17 per share. After $-0.19 actual EPS reported by Novadaq Technologies Inc. for the previous quarter, Wall Street now forecasts -21.05% EPS growth.
Novadaq Technologies Inc. (NASDAQ:NVDQ) Ratings Coverage
Out of 4 analysts covering Novadaq Technologies Inc (NASDAQ:NVDQ), 4 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Novadaq Technologies Inc has been the topic of 6 analyst reports since October 7, 2015 according to StockzIntelligence Inc. The rating was initiated by JMP Securities with “Mkt Outperform” on Wednesday, January 6. First Analysis upgraded Novadaq Technologies Inc. (NASDAQ:NVDQ) on Thursday, October 29 to “Overweight” rating. The stock of Novadaq Technologies Inc. (NASDAQ:NVDQ) earned “Outperform” rating by Wedbush on Wednesday, October 7.
According to Zacks Investment Research, “Novadaq Technologies Inc. develops, manufactures and markets real-time fluorescence imaging products for use in the operating room and other clinical settings. The company’s key markets include plastic reconstructive, gastrointestinal, cardiac and general surgery. It provides SPY imaging systems which enables surgeons to the visualize blood flow in vessels, co-joined vessels and micro-vessels. Novadaq Technologies Inc. is headquartered in Mississauga, Canada.”
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.